Conference Call and Webcast at 8:30AM Eastern Time
NEW
YORK, Oct. 30, 2024 /PRNewswire/ -- Lucid
Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the
"Company") a commercial-stage, cancer prevention medical
diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM),
today announced that it will host a business update conference call
and webcast on Wednesday, October 13,
2024, at 8:30 AM ET. During
the call, Lishan Aklog, M.D.,
Lucid's Chairman and Chief Executive Officer, will provide a
business update, including an overview of the Company's operations
and continued growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer,
will discuss the Company's third quarter 2024 financial
results.
The webcast will be available at the investor
relations section of the Company's website at luciddx.com.
Alternatively, to access the conference call by telephone,
U.S.-based callers should dial 1-800-836-8184 and international
listeners should dial 1-646-357-8785. All listeners should provide
the operator with the conference call name "Lucid Diagnostics
Business Update" to join.
Following the conclusion of the conference call, a replay will
be available for 30 days on the investor relations section of the
Company's website at luciddx.com.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a
commercial-stage, cancer prevention medical diagnostics company,
and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on
the millions of patients with gastroesophageal reflux disease
(GERD), also known as chronic heartburn, who are at risk of
developing esophageal precancer and cancer. Lucid's
EsoGuard® Esophageal DNA Test, performed on samples
collected in a brief, noninvasive office procedure with its
EsoCheck® Esophageal Cell Collection Device, represent
the first and only commercially available tools designed with the
goal of preventing cancer and cancer deaths through widespread,
early detection of esophageal precancer in at-risk patients.
For more information, please visit www.luciddx.com and for more
information about its parent company PAVmed, please visit
www.pavmed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-november-13-2024-302291335.html
SOURCE Lucid Diagnostics
